21-Gene Recurrence Score Decreases Receipt of Chemotherapy in ER+ Early-Stage Breast Cancer: An Analysis of the NCDB 2010–2013
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-016-3926-5
Full Text
Open PDFAbstract
Available in full text
Date
August 9, 2016
Authors
Publisher
Springer Science and Business Media LLC